Green Charles Bruce 4
4 · Humacyte, Inc. · Filed Sep 19, 2022
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Green Charles Bruce
Director
Transactions
- Award
Stock Options (right to buy)
2022-09-15+13,000→ 13,000 totalExercise: $4.09Exp: 2032-09-15→ Common Stock (13,000 underlying)
Footnotes (1)
- [F1]The first 25% of the option becomes exercisable on September 15, 2023, after which 1/48 of the option will become exercisable on the 15th of each month through September 15, 2026.